Section Arrow
NCNA.NASDAQ
- NuCana plc
Quotes are at least 15-min delayed:2025/05/29 01:15 EDT
Last
 0.0375
-0.0015 (-3.85%)
Day High 
0.0398 
Prev. Close
0.039 
1-M High
1.25 
Volume 
57.89M 
Bid
0.037
Ask
0.038
Day Low
0.0356 
Open
0.038 
1-M Low
0.0325 
Market Cap 
236.22K 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.04 
20-SMA 0.23 
50-SMA 0.58 
52-W High 10.79 
52-W Low 0.0325 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.50/-11.55
Enterprise Value
353.22K
Balance Sheet
Book Value Per Share
1.32
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.7064+0.4689+197.43%-- 
SPROSpero Therapeutics2.35+1.668+244.57%9.58PE
NCNANuCana plc0.0375-0.0015-3.85%-- 
PLRZPolyrizon Ltd1.03+0.384+59.44%-- 
VERUVeru0.5286+0.0196+3.85%-- 
Quotes are at least 15-min delayed:2025/05/29 01:15 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.